Multiple trichoepitheliomas associated with a novel heterozygous mutation in the cyld gene as an adjunct to the histopathological diagnosis

American Journal of Dermatopathology

Volumn 35, Issue 4, 2013, Pages 445-447

  Reuven, Bergman ^a,b,c   Margarita, Indelman ^a   Dov, Hershkovitz ^b,c   Ziad, Khamaysi ^a  

^a Rambam Health Care Campus ^*  (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Rambam Health Care Campus   (Israel)

Author keywords

CYLD; multiple; mutation; trichoepitheliomas

Indexed keywords

BIOLOGICAL MARKER; CYLD PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; TRICHOEPITHELIOMA;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR SEQUENCE DATA; NEOPLASTIC SYNDROMES, HEREDITARY; PHENOTYPE; PREDICTIVE VALUE OF TESTS; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84878902290     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31827132af     Document Type: Article

References (28)

1. Kirchmann TT, Prieto VG, Smoller BR. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch Dermatol. 1994;130:589-592. (Pubitemid 24150937)
2. Verhaegh ME, Arends JW, Majoie IM, et al. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma. Dermatol Surg. 1997;23:695-700. (Pubitemid 27329833)
3. Thewes M, Worret WI, Engst R, et al. Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma. Am J Dermatopathol. 1998;20:140-142. (Pubitemid 28164961)
4. Swanson PE, Fitzpatrick MM, Ritter JH, et al. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol. 1998;25: 153-159. (Pubitemid 28130161)
5. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol. 1999;21:332-336. (Pubitemid 29359935)
6. Izikson L, Bhan A, Zembowicz A. Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumors. Am J Dermatopathol. 2005;27:91-95. (Pubitemid 40471092)
7. Pham TT, Selim MA, Burchette JL Jr, et al. CD10 expression in trichoepithelioma and basal cell carcinoma. J Cutan Pathol. 2006;33:123-128.
8. Katona TM, Perkins SM, Billings SD. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma? J Cutan Pathol. 2008;35:174-179.
9. Costache M, Bresch M, Böer A. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation. Histopathology. 2008;52:865-876. (Pubitemid 351724908)
10. Krahl D, Sellheyer K. p75 neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology. Br J Dermatol. 2010;163:138-145.
11. Abbas O, Richards JE, Mahalingam M. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma. Mod Pathol. 2010;23:1535-1543.
12. Sellheyer K, Krahl D. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma. Br J Dermatol. 2011;164:141-147.
13. Sellheyer K, Nelson P. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens. J Cutan Pathol. 2011;38: 542-550.
14. Ansai SI, Takayama R, Kimura T, et al. Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms. J Dermatol. 2012;39:688-692.
15. Heidarpour M, Rajabi P, Sajadi F. CD10 expression helps to differentiate basal cell carcinoma from trichoepithelioma. J Res Med Sci. 2011;16:938-944.
16. Arits AH, Van Marion AM, Lohman BG, et al. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview. Eur J Dermatol. 2011; 21:870-873.
17. Abdelsayed RA, Guikarro-Rojas M, Ibrahim NA, et al. Immunohistochemical evaluation of basal cell carcinoma and trichoepithelioma using Bcl-2, Ki67, PCNA and P53. J Cutan Pathol. 2000;27:169-175. (Pubitemid 30162612)
18. Lum CA, Binder SW. Proliferative characterization of basal-cell carcinoma and trichoepithelioma in small biopsy specimens. J Cutan Pathol. 2004;31:550-554. (Pubitemid 39061804)
19. Cesinaro AM,MigaldiM, Corrado S, et al. Expression of p27kip1 in basal cell carcinomas and trichoepitheliomas. Am J Dermatopathol. 2002;24:313-318. (Pubitemid 34810307)
20. Gray HR, Helwig EB. Epithelioma adenoides cysticum and solitary trichoepithelioma. Arch Dermatol. 1963;87:102-114.
21. Schuelke M. An economic method for the fluorescent labeling of PCR fragments. Nat Biotechnol. 2000;18:233-234. (Pubitemid 30091190)
22. Huang TM, Chao SC, Lee JY. A novel splicing mutation of the CYLD gene in a Taiwanese family with multiple familial trichoepithelioma. Clin Exp Dermatol. 2009;34:77-80.
23. Kazakov DV, Vanecek T, Zelger B, et al. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients. Am J Dermatopathol. 2011;33:251-265.
24. Almeida S, Maillard C, Itin P, et al. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol. 2008;128:587-593. (Pubitemid 351252652)
25. Hutti JE, Shen RR, Abbott DW, et al. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell. 2009;34:461-472.
26. Harada H, Hashimoto K, Ko MS. The gene for multiple familial trichoepithelioma maps to chromosome 9p21. J Invest Dermatol. 1996;107:41-43. (Pubitemid 26236092)
27. Linos K, Schwartz J, Kazakov DV, et al. Recurrent CYLD nonsense mutation associated with a severe, disfiguring phenotype in an African American family with multiple familial trichoepithelioma. Am J Dermatopathol. 2011;33:640-642.
28. Kazakov DV, Vanecek T, Nemcova J, et al. Spectrum of tumors with follicular differentiation in a patient with the clinical phenotype of multiple familial trichoepitheliomas: a clinicopathological and molecular biological study, including analysis of the CYLD and PTCH genes. Am J Dermatopathol. 2009:31;819-827.